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Introduction
Lung cancer has become the leading cause of  cancer 
deaths in mainland China, and more than 24600 people 
died of  lung cancer in the year 2008[1]. Lung cancer 
was often diagnosed at an advanced stage with poor 
prognosis. Anecdotal data shows that  80% of  lung 
cancer cases are  diagnosed at stage 3 or 4 in the general 
hospitals in China. Patients with lung cancer experience 
a variety of  distressing symptoms, many of  which begin 
prior to diagnosis and continue throughout the course 
of  the disease and its treatment, adversely affecting 
functional status and quality of  life (QOL). Compared 
to other types of  cancer, the distress associated with 
symptoms arising from lung cancer has  been reported 
as the most intense[2]. Part of  the symptom burden 
experienced by patients with lung cancer may be the
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result of  the simultaneous occurrence of  symp-
toms, also known as “clustering” of  symptoms. The 
term“symptom clusters” has been defined as two or 
more interrelated symptoms that are present togeth-
er, independent of  other symptom clusters, and may 
or may not suggest a common etiology or underlying 
mechanism [3-5]. Research has provided evidence  that, 
together, multiple symptoms may have more negative 
effects on patients’ quality of  life than the occurrence 
of  single symptoms [6,7].
Most research on symptoms has been directed 
towards a single symptom, such as pain or fatigue, or 
symptoms that were correlated with a single symptom. 
However, the symptoms generally occurred at the 
same time and there were synergic relationships among 
them that resulted in negative impact on QOL[8]. 
Thus, the exploration of  the impact of  simultaneous 
symptoms on QOL domains in lung cancer patients, 
and the understanding of  symptom synergism, became 
important for  successful achievement of  cancer 
treatment. Establishing  the best strategies to reduce 
the impact of  cancer and treatment-related symptoms, 
and to improve QOL, are important . Appropriate 
symptom control, considering symptom interactions, 
should be a priority for patients with lung cancer. In 
addition, effective symptom management might  lessen 
or negate these effects and improve lung cancer patients’ 
quality of  life.
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Abstract
Objective: To explore the symptom clusters and quality of  life in patients with lung cancer undergoing chemotherapy.
Methods: A cross-sectional survey was completed with 183 patients from three public hospitals in Xi’an, China. Patients 
completed a demographic questionnaire, the Functional Assessment of  Cancer Therapy-Lung Cancer (FACT-L) and the M. 
D. Anderson Symptom Inventory (MDASI-C). Factor analysis was used to identify symptom clusters based on the severity 
of  patients’ symptom experiences. The resulting clusters were correlated with quality-of-life measures.
Results: The QOL scores of  lung cancer patients on the functioning subscale were the lowest (9.70±5.30), while those of  
the family subscale were the highest (19.28±3.24). Three symptom clusters were identified: gastrointestinal, emotional and 
fatigue–related symptoms. There was a negative relationship between the symptom clusters and multiple dimensions of  
quality of  life (r -0.178～-0.805, p< 0. 05). Females, especially those women with low education level /chronic diseases, were 
experienced greater symptom distress than others.
Conclusions: The clusters had a negative relationship with QOL. Identifying symptom clusters helped clarify possible inter-
relationships which may lead to the establishment of  more effective symptom management interventions for patients with 
lung cancer in order to improve the quality of  life.
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Therefore, the objectives  of  this study were 
to (1) describe symptom experienced by patients with 
lung cancer undergoing chemotherapy; (2) explore 
whether multiple symptoms were clustered into groups 
of  symptoms; (3) examine whether symptom clusters 
were related to demographic, health characteristics; 
(4) identify the impact of  symptom clusters on QOL 
dimensions
Various theoretical frameworks were available to 
guide our understanding of  symptom clusters. We used 
the theory of  unpleasant symptoms (TOUS), which has 
been utilized frequently in symptom cluster research 
[9-12]. TOUS has three main reciprocal components: 
symptoms, influential factors, and performance. 
According to the theory, each symptom has four 
dimensions: intensity, timing, level of  distress perceived 
and quality. The symptoms of  the effecting factor include 
physiological, psychological, and situational antecedents. 
Performance is the consequence of  the symptom 
experience, which covered functional and cognitive 
activities. This model provides a theoretical framework 
for research on symptom clusters by indentifying 
multiplicative effects of  multiple concurrent symptoms. 
In the theory of  unpleasant symptoms, Lenz[13] 
proposed that symptom clusters have a resultant effect 
on important patient outcomes, such as QOL.
Methods
Design
A cross-sectional study design was used with a convenient 
sample of  patients from three public hospitals in Xi’an 
from January to June of  2012. 
Sample and Settings
The research criteria for the sample was determined 
to reflect the following conditions: (1) receiving 
chemotherapy for lung cancer at any stage of  their 
chemotherapy, and any cycle; (2) 18 years of  age or 
older; (3)  able to understand and speak Chinese, and 
(4) absence of  cognitive impairment. 
    A total of  200 patients were approached and invited 
to participate. Among them, 183 patients responded to 
the study invitation. Seventeen patients (8.5%) were too 
sick to complete the questionnaires, or were prevented 
from participating by a family member. 
Procedures
After the hospital ethics committee approved the study, 
eligible patients were screened and those meeting the 
selection criteria were invited to participate in the 
study. The research assistant contacted all patients and 
provided a verbal explanation of  study. All patients 
were informed that their participation was voluntary, 
they would remain anonymous, they could withdraw 
from the study at any time without penalty, and all 
information would be kept confidential. After obtaining 
consent, all participants completed the MDASI-C, 
FACT-L and Demographic and Medical questionnaires. 
Research assistants were available on site during the 
administration of  the questionnaires and provided 
explanation. The participant’s demographic and clinical 
data was obtained through personal interview and the 
review of  their medical records. The time required to 
complete the questionnaire was approximately 20～30 
minutes. 
Instrument
The study instruments included a demographic and 
clinical questionnaire, the Functional Assessment 
of  Cancer Therapy-Lung Cancer (FACT-L) and the 
M. D. Anderson Symptom Inventory-the Chinese 
version～MDASI-C～.
The demographic and clinical questionnaire
The demographic information included the gender, 
age, family monthly income, type of  medical insurance, 
marital status, educational level, religious affiliation 
and employment status. The clinical information were 
about the type of  cancer, extent of  disease, presence of  
metastatic disease, and whether there was coexistence 
with other chronic diseases .
Chinese Version of  the M. D. Anderson Symptom Inventory 
(MDASI-C)
The MDASI-T was used to measure the severity of  
symptoms and the degree to which they interfered 
with daily life. The MDASI had been established as 
a valid and reliable tool for assessing cancer-related 
symptoms, regardless of  therapy or specific diagnosis. 
It contained 13 core symptom severity items (that 
is: fatigue, sleep disturbance, pain, drowsiness, lack 
of  appetite, nausea, vomiting, shortness of  breath, 
numbness, difficulty remembering, dry mouth, distress, 
and sadness) which could explain 64% of  the variance 
in symptom interference, and six symptom interference 
items (that is: general activity, mood, work, relations 
with other people, walking, and enjoyment of  life). A 
severity composite score was computed by averaging 
the scores for the 13 severity items. An interference 
composite score was computed by averaging the scores 
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for the six symptom interference items. The MDASI 
was rated from 0 (symptom has not been present) to 
10 (the symptom was as bad as I could imagine it to be) 
for each item. Internal consistencies of  the symptom 
severity and the symptom in Chinese version were 0.82
～0.94. Most patients completed the form in 5 minutes. 
The Functional Assessment of  Cancer Therapy-Lung Cancer 
(FACT-L)
Quality of  life was measured using the Chinese version 
of  the Functional Assessment of  Cancer Therapy V 
Lung cancer (FACT-L 4.0) developed specifically for 
patients with lung cancers[14]. Functional Assessment 
of  Cancer Therapy V Lung cancer contained the 
original FACT-General scales that included a 27-item 
compilation of  general questions divided into 4 primary 
QOL domains: physical (7 items), social/family(7 
items), emotional (6 items), and functional well-being(7 
items). The additional 9 items were used to assess 
disease-specific issues in patients with lung cancer[14]. 
The subjects circle numbers on a scale were from 0 (not 
at all) to 4 (very much) indicating their reaction to each 
statement. Higher scores for the scales and subscales 
indicated better QOL. The possible total scores ranged 
from 0 to 144. In this study, internal consistency of  
FACT-L (Chinese version 4.0) was 0.56～0.82, whereas 
the test-retest reliability was0.76～0.82[15].
Statistical Analysis
Data were stored and analyzed using SPSS version 13.0. 
Frequency distributions and descriptive statistics were 
used to analyze the demographic, socioeconomic, and 
clinical data, the scores on each symptom and QOL 
questionnaires (the subscales and the global QOL 
scores).
Exploratory factor analysis with principal axis 
factoring was used to identify symptom clusters. 
Varimax rotation was used to maximize the variance of  
the loadings within each component while assuming the 
independence of  the component structure Spearman 
correlations was utilized to examine correlations 
between symptom clusters and QOL: total score of  all 
symptoms of  each symptom cluster and global QOL 
score, score of  each dimension of  QOL.
Results
Demographic characteristics and clinical information
A total of  183 participants undergoing chemotherapy 
were recruited. Most of  the participants (63.9%) were 
male. The mean age was 58.25 years (SD = 10.31, range 
= 32～84). A large number of  participants (n = 174) 
were married (95.1%); 66.7% were unemployed, 56.3% 
were educated 9 years or less, and 90% had no religious 
beliefs, a typical characteristic of  Chinese culture. 
The diagnosis of  non-small-cell lung cancer 
(NSCLC) comprised 80.9% and 31.2% for small-
cell lung cancer (SCLC). Patients with stage IV non-
small-cell lung cancer (NSCLC) accounted for 38.8%, 
while those with stage III non-small-cell lung cancer 
(NSCLC) totaled 22.4%. Patients with extensive-stage 
small-cell lung cancer (SCLC) comprised only 6.0% of  
the sample. More details of  demographic and clinical 
data were presented in Table 1.
African Health sciences Vol 14 No. 1 March 2014
Table 1 Demographic characteristics and clinical information
Variable n （%（ M(SD) Variable n （%（
Age ～58.25±10.31～ Diagnosis
Gender Small cell lung cancer 35 19.1%
Male 117 63.9% Non-small cell lung cancer 148 80.9%
Female 66 36.1% Stage of  disease
Marital status Non-small cell lung cancer II 36 19.7%
Singe 4 2.2% Non-small cell lung cancer III 41 22.4%
Married 174 95.1% Non-small cell lung cancer IV 71 38.8%
Divorced 5 2.7% Limited-stage small cell lung cancer 24 13.1%
Education Extensive-stage small cell lung cancer 18 9.8%
Primary school 53 29.0% Family monthly income
Junior school 50 27.3% Less than 1,000 79 43.2%
Senior school 44 24.0% 1,000～2,000 40 21.9%






Occupation Coexistence with other chronic 
diseases
No 122 66.7% Yes 53 29.0%




       51
The prevalence and severity of  lung cancer patients’ symptoms
The top three prevalent symptoms among 
participants were tiredness (99.5%); distressed (98.9%), 
and lack of   appetite (97.3%); whereas the rarest 
symptom was numbness (43.2%). The average symptom 
severity was graded 4.0, which indicated symptoms 
disturbance with a mild-to-moderate level. Moreover, 
the top three severe symptoms experienced by the 
participants were fatigue, dry mouth, and shortness of  
breath. The prevalence and severity of  symptoms were 
listed in Table 2.






Lack of  appetite 178～97.3%～ 4.86±2.11
Shortness of  breath 164～89.6%～ 4.88±2.52
Disturbed sleep 175～95.6%～ 4.58±2.07
Distressed 181～98.9%～ 4.26±1.96
Nausea 150～82.0%～ 3.91±2.66





Disturbed sleep 142～77.6%～ 2.36±1.87
Numbness 79～43.2%～ 1.39±2.03
Symptom clusters
The exploratory factor analysis with principal 
axis factoring was used to extract symptom clusters, 
and the Varian rotation was used to simplify the factor 
structure. In this study, variables with item–total 
correlation coefficient less than 0.4 were excluded 
because statistically a correlation with a lower than that 
will produce too many factors in factor analysis. Three 
distinct factors with Eigen values greater than 1.0 were 
retained, accounting for 69.4% of  the total variance. 
The first factor, that is, gastrointestinal symptom cluster 
included nausea and vomiting. The second factor, 
fatigue-related cluster includes feeling fatigued, pain, 
and disturbed sleep. The third factor, emotional cluster, 
consisted of  symptoms of  sadness, and distress (Table 
3).
Table 3 The Symptom Clusters in lung cancer (n=183)






Fatigue related disturbed sleep 0.826
disturbed sleep 0.527
pain 0.450
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Relationship of  symptom clusters to demographic and clinical 
information 
For demographic variables, the gender differences were 
identified as statistically significant in each factor, which 
indicated that females reported statistically higher 
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troubling symptoms than males. Education differences 
among the three symptom clusters were statistically 
significant. Chronic illnesses were significantly related 
to gastrointestinal symptom clusters as shown in table 
4.
Table 4 The correlations among demographic characteristics
Variable Factor1 Factor2 Factor3
t/F P t/F P t/F P
Gender -2.99 .01 -2.32 .02 -2.18 .03
Stage of  disease 5.73 .001 5.94 .001 4.81 .001
chronic diseases 2.45 .04
 
Relationship between symptom clusters and quality of  life 
The results demonstrated the descriptive statistics 
for the FACT-L total and its subscales. The highest 
HRQOL score for the total sample was the lung cancer 
subscale dimension, followed by the social dimension. 
The lowest score was the role functioning dimension, 
followed by the emotional dimension. Pearson 
correlations were computed between the symptom 
cluster scale scores and the quality-of-life measurements 
and the results are in table 5.





   
Fatigue related
FACT-L
Physical well-being 14.38±4.72 -.655 -.697 -.749
Social/family well-being 19.28±3.24 -.178 -.302 -.257
Emotional well-being 13.20±4.37 -.358 -.805 -.617
Functional well-being 9.70±5.30 -.411 -.749 -.696
Lung cancer subscale 20.89±5.55 -.332 -.508 -.485
Discussion
The results of  this study have provided important 
insights into the symptom experiences and the 
relationship between symptom clusters and quality of  
life in patients with lung cancer in mainland China. 
Lung cancer remains  the leading cause of  cancer 
death in mainland China. However, studies describing 
the experiences of  patients living with lung cancer in 
mainland China are limited. To our knowledge, this is 
the first study in mainland China, to explore symptom 
clusters as well as test the relationship between symptom 
clusters and quality of  life in a homogeneous group of  
lung cancer patients.
Tiredness, distress, and lack of  appetite were the 
most prevalent symptoms in this study. This result was 
similar to that from previous studies[16-18]. Concerning 
severity of  symptoms, our result showed fatigue, dry 
mouth, and shortness of  breath as the most severe, 
was similar to Semiha Akin ‘s [19] findings. The results 
of  this study indicate lung cancer patients in mainland 
China suffered from a severe level of  symptom distress 
similar to what is experienced in Europe and north 
America.  Three factors were identified this study. 
Gastrointestinal symptom cluster included nausea and 
vomiting, which was similar to the research of  Wang, 
SY et al[20]. Gastrointestinal symptom cluster probably 
resulted from  the side effects of  chemotherapy. 
Fatigue-related cluster composed of  feeling fatigued, 
pain, and disturbed sleep. These sickness behaviors 
were considered to be mediated by proinflammatory 
cytokines[21,22]. Emotional cluster which was a more 
psychologically related cluster consisted of  symptoms 
of  sad, and distressed. Historically, cancer symptom 
research had focused on a single symptom at a time, but 
now, we were aware that the patients with lung cancer 
often have multiple concurrent symptoms and may 
exacerbate one another. Furthermore, assessing possible 
symptom grouping simultaneously, systematically and 
comprehensively and therefore treated; interest in the 
effectively symptom management of  cancer patients 
should pay more attentions to symptom clusters instead 
of  only to individual symptoms.
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It was found to be correlated with all symptom 
clusters in this study were gender and education. 
Weakness, psychological vulnerability was the nature of  
female patients leading to more symptom burden than 
male. The difference caused by education was similar 
to the previous research[23]. Patients who received 
high education will have early recognition of  cancer 
and seek treatment actively. The weak correlations 
between symptom cluster and chronic disease might 
be explained by two reasons. Firstly, the symptoms of  
chronic disease itself  will contribute to cancer symptom 
cluster. Secondly, lung cancer patients with  chronic 
diseases produce  more economic and psychological 
burden than patients without.
In this study, we found lung cancer patients had low 
QOL scores. The functioning subscale scores were the 
lowest, while the family subscale scores were the highest. 
The current study found a negative relationship between 
symptom clusters and QOL scores. Generally, almost 
all three symptom clusters were negatively correlated 
with PWB, EWB, FWB, SWB, and overall QOL. In 
this study, physical quality of  life was highly correlated 
with all symptom clusters. Another particularly strong 
relationship was between the emotional cluster and 
emotional well-being in quality of  life. This finding was 
consistent with other studies[24-26].
Overall QOL was important for patients with lung 
cancer. Therefore, symptom and QOL assessments 
were vital for the evaluation of  the efficacy of  cancer 
treatments. Patients with cancer experienced different 
levels of  symptom distress according to disease 
and treatment. According to our finding, symptom 
management should be taken into account in order to 
decrease the negative effects of  symptom clusters on 
QOL. Further studies should include a larger sample to 
more fully describe the potential interactive effects of  
the dependent variables on QOL.
Limitations and methodological issues:
Firstly, the MDASI was a relatively short instrument that 
assessed only13 symptoms.  As we know, using different 
tools of  symptoms may result in different symptom 
clusters. We therefore suggested a more comprehensive 
tool should be used to assess symptoms when exploring 
the phenomenon of  symptom clusters. Secondly, the 
current study of  symptom clusters had been conducted 
by cross-sectional design. A future study was needed 
to explore long-term changes of  symptom clusters and 
its association with physical, psychological, and clinical 
variables.
Conclusions
Lung cancer patients receiving chemotherapy suffered 
from numerous symptoms simultaneously, due to the 
disease itself  as well as treatment. The results of  this 
study have provide understanding of  symptom clusters 
which could help clinicians develop more comprehensive 
and useful assessment tools as well as more effective 
symptom management strategies to improve the quality 
of  life for patients with lung cancer in china.
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